Jefferies Upgrades Tango Therapeutics to Buy, Raises Price Target to $60
Benzinga Newsdesk 4 months ago
NewsUpgradesAnalyst RatingsPrice Target
Jefferies analyst Maury Raycroft upgrades Tango Therapeutics (NASDAQ:TNGX) from Hold to Buy and raises the price target from $27 to $60.
Jefferies analyst Maury Raycroft upgrades Tango Therapeutics (NASDAQ:TNGX) from Hold to Buy and raises the price target from $27 to $60.